JPWO2022195074A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022195074A5
JPWO2022195074A5 JP2023557131A JP2023557131A JPWO2022195074A5 JP WO2022195074 A5 JPWO2022195074 A5 JP WO2022195074A5 JP 2023557131 A JP2023557131 A JP 2023557131A JP 2023557131 A JP2023557131 A JP 2023557131A JP WO2022195074 A5 JPWO2022195074 A5 JP WO2022195074A5
Authority
JP
Japan
Prior art keywords
pkp2
fold
gene therapy
isoform
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512483A5 (https=
JP2024512483A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/057145 external-priority patent/WO2022195074A2/en
Publication of JP2024512483A publication Critical patent/JP2024512483A/ja
Publication of JPWO2022195074A5 publication Critical patent/JPWO2022195074A5/ja
Publication of JP2024512483A5 publication Critical patent/JP2024512483A5/ja
Pending legal-status Critical Current

Links

JP2023557131A 2021-03-19 2022-03-18 遺伝子治療組成物及び不整脈原性右室心筋症の治療 Pending JP2024512483A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163163393P 2021-03-19 2021-03-19
US63/163,393 2021-03-19
PCT/EP2022/057145 WO2022195074A2 (en) 2021-03-19 2022-03-18 Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathy

Publications (3)

Publication Number Publication Date
JP2024512483A JP2024512483A (ja) 2024-03-19
JPWO2022195074A5 true JPWO2022195074A5 (https=) 2025-03-27
JP2024512483A5 JP2024512483A5 (https=) 2025-03-27

Family

ID=81384690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557131A Pending JP2024512483A (ja) 2021-03-19 2022-03-18 遺伝子治療組成物及び不整脈原性右室心筋症の治療

Country Status (12)

Country Link
US (1) US20240042059A1 (https=)
EP (1) EP4308172A2 (https=)
JP (1) JP2024512483A (https=)
KR (1) KR20230159471A (https=)
CN (1) CN117715660A (https=)
AU (1) AU2022239846A1 (https=)
BR (1) BR112023018944A2 (https=)
CA (1) CA3212043A1 (https=)
IL (1) IL305959A (https=)
MX (1) MX2023011035A (https=)
TW (1) TW202300180A (https=)
WO (1) WO2022195074A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114450411A (zh) 2019-04-01 2022-05-06 特纳亚治疗股份有限公司 具有工程化衣壳的腺相关病毒
JP2023538519A (ja) 2020-08-07 2023-09-08 スペースクラフト セブン リミテッド ライアビリティ カンパニー Aavベクターを使用したプラコフィリン-2(pkp2)遺伝子治療
US11781156B2 (en) 2020-10-09 2023-10-10 Tenaya Therapeutics, Inc. Plakophillin-2 gene therapy methods and compositions
IL301675A (en) 2020-10-09 2023-05-01 Tenaya Therapeutics Inc Methods and preparations for placophilin-2 gene therapy
CN115851751A (zh) * 2022-12-21 2023-03-28 百世诺(北京)医疗科技有限公司 肥厚型心肌病变异基因tnnt2及其应用
WO2025189238A1 (en) * 2024-03-12 2025-09-18 Murdoch Children's Research Institute Treatment methods for muscle-associated diseases
WO2025238184A1 (en) * 2024-05-15 2025-11-20 Stichting Amsterdam UMC Scn10a-short gene therapy to restore cardiac impulse conduction and to protect against cardiac arrhythmia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186369B2 (en) * 2017-09-20 2025-01-07 The Regents Of The University Of California Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy
US12098385B2 (en) * 2017-09-20 2024-09-24 The Regents Of The University Of California Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy
CN109004092A (zh) 2018-06-29 2018-12-14 云谷(固安)科技有限公司 有机电致发光器件和有机电致发光装置
KR20220066914A (ko) * 2019-09-20 2022-05-24 유씨엘 비즈니스 리미티드 부정맥 유발성 우심실 심근병증의 유전자 요법 조성물 및 치료
JP2023538519A (ja) * 2020-08-07 2023-09-08 スペースクラフト セブン リミテッド ライアビリティ カンパニー Aavベクターを使用したプラコフィリン-2(pkp2)遺伝子治療
US11781156B2 (en) * 2020-10-09 2023-10-10 Tenaya Therapeutics, Inc. Plakophillin-2 gene therapy methods and compositions
IL301675A (en) * 2020-10-09 2023-05-01 Tenaya Therapeutics Inc Methods and preparations for placophilin-2 gene therapy

Similar Documents

Publication Publication Date Title
US12257317B2 (en) Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
Grieger et al. Adeno-associated virus vectorology, manufacturing, and clinical applications
JP2022190081A5 (https=)
US12491265B2 (en) Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
JP2021512649A5 (https=)
RU2017125234A (ru) Конструкции нуклеиновой кислоты и векторы для генотерапии для применения для лечения болезни вильсона и других состояний
FI3628334T3 (fi) Geenihoito verkkokalvon pigmenttirappeuma
JPWO2021053222A5 (https=)
JPWO2020106916A5 (https=)
JP2020519284A5 (https=)
JPWO2019152609A5 (https=)
JP2021523702A5 (https=)
IL292264B1 (en) Aav transfer cassette
JP2020509786A5 (https=)
JP2021520811A5 (https=)
JP2023059858A5 (https=)
JPWO2022195074A5 (https=)
IL319564A (en) BAG 3 methods and uses for treating cardiac amyloidosis
JPWO2019204593A5 (https=)
US20240318198A1 (en) Gene therapy for angelman syndrome
JPWO2021076911A5 (https=)
JPWO2019200286A5 (https=)
JPWO2021050991A5 (https=)
JPWO2022235933A5 (https=)